12:00 AM
 | 
Mar 27, 2006
 |  BioCentury  |  Finance

BioMarin chronicles

BioMarin chronicles

Weekly stock price of BioMarin (BMRN; SWX:BMRN) tracked against selected events since the start of 2004.

A. 4/21/04 - BMRN says it will pay $175M for the Ascent Pediatrics business of Medicis (MRX) in a move to become a "fully integrated pediatrics-focused biopharmaceutical company." The deal provides Orapred, a corticosteroid to treat asthma in children, and...

Read the full 282 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >